MedPath

MILLET GREGOIRE

🇫🇷France
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (100.0%)

Intermittent Hypoxia-hyperoxia Conditioning as a New Therapeutic Intervention to Reduce Hypertension (HyperIHHC)

Not Applicable
Not yet recruiting
Conditions
Hypertension
First Posted Date
2022-11-03
Last Posted Date
2022-11-03
Lead Sponsor
Gregoire Millet
Target Recruit Count
72
Registration Number
NCT05603676
Locations
🇨🇭

ISSUL, Lausanne, VD, Switzerland

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.